Nihon Kohden Corporation and Abbott enter into agreement for automated hematology analyzers
February 17, 2005
ABBOTT PARK, IL, USA and TOKYO, JAPAN - Abbott and Nihon Kohden Corporation announced today that they have entered into an agreement for commercialization of automated hematology analyzers. Two 5-part differential hematology analyzers will be manufactured by Nihon Kohden and distributed by Abbott under the CELL-DYN(R) Pearl brand name. Abbott's CELL-DYN family of hematology instruments are well-respected around the world and Nihon Kohden is proud to have its high quality hematology analyzers recognized by one of the major companies in this field.
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs more than 60,000 people and markets its products in more than 130 countries. Abbott's news releases and other information are available on the company's Web site at www.abbott.com.
Nihon Kohden is Japan's leading manufacturer, developer and distributor of patient monitors, hematology analyzers, EEGs, EP/EMGs, ECGs, defibrillators and other medical electronic equipment with subsidiaries in the United States, Europe and Asia and distributors in nearly every country in the world. For more information, visit the Company's web site at www.nihonkohden.com.
